Producing human livers from human stem cells via blastocyst complementation

The need for organ transplants exceeds donor organ availability. In the quest to solve this shortage, the most remarkable area of advancement is organ production through the use of chimeric embryos, commonly known as blastocyst complementation. This technique involves the combination of different sp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in biomedical engineering 2024-09, Vol.31, p.100537, Article 100537
Hauptverfasser: Ahmadzada, Boyukkhanim, Felgendreff, Philipp, Minshew, Anna M., Amiot, Bruce P., Nyberg, Scott L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 100537
container_title Current opinion in biomedical engineering
container_volume 31
creator Ahmadzada, Boyukkhanim
Felgendreff, Philipp
Minshew, Anna M.
Amiot, Bruce P.
Nyberg, Scott L.
description The need for organ transplants exceeds donor organ availability. In the quest to solve this shortage, the most remarkable area of advancement is organ production through the use of chimeric embryos, commonly known as blastocyst complementation. This technique involves the combination of different species to generate chimeras, where the extent of donor cell contribution to the desired tissue or organ can be regulated. However, ethical concerns arise with the use of brain tissue in such chimeras. Furthermore, the ratio of contributed cells to host animal cells in the chimeric system is low in the production of chimeras associated with cell apoptosis. This review discusses the latest innovations in blastocyst complementation and highlights the progress made in creating organs for transplant.
doi_str_mv 10.1016/j.cobme.2024.100537
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3066335995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2468451124000175</els_id><sourcerecordid>3066335995</sourcerecordid><originalsourceid>FETCH-LOGICAL-c284t-990ac986660ca9111e054faea81eb1a37dcf35f7ec41f80c96ffc4da9fd64c193</originalsourceid><addsrcrecordid>eNp9kE1PwzAMhiMEggn4BUioRy4dyfKx5MABTXyJSXCAc5S5DmRqm5G0k_j3dGwgTpxs2a_92g8hZ4yOGWXqcjmGuGhwPKETMVSo5NM9MpoIpUshGdv_kx-R05yXlFKmJRVaHpIjrrUUgqsReXxOseohtG_Fe9-4tqjDGlMufIrNrpI7bArAus7FOrhiUbvcRfjMXQGxWdXYYNu5LsT2hBx4V2c83cVj8np78zK7L-dPdw-z63kJEy260hjqwGilFAVnGGNIpfAOnWa4YI5PK_Bc-imCYF5TMMp7EJUzvlICmOHH5GK7d5XiR4-5s03ImwNdi7HPllOlOJfGyEHKt1JIMeeE3q5SaFz6tIzaDUi7tN8g7Qak3YIcps53Bv3Qqn5nfrANgqutAIc31wGTzRCwBaxCQuhsFcO_Bl_yBIXh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3066335995</pqid></control><display><type>article</type><title>Producing human livers from human stem cells via blastocyst complementation</title><source>Alma/SFX Local Collection</source><creator>Ahmadzada, Boyukkhanim ; Felgendreff, Philipp ; Minshew, Anna M. ; Amiot, Bruce P. ; Nyberg, Scott L.</creator><creatorcontrib>Ahmadzada, Boyukkhanim ; Felgendreff, Philipp ; Minshew, Anna M. ; Amiot, Bruce P. ; Nyberg, Scott L.</creatorcontrib><description>The need for organ transplants exceeds donor organ availability. In the quest to solve this shortage, the most remarkable area of advancement is organ production through the use of chimeric embryos, commonly known as blastocyst complementation. This technique involves the combination of different species to generate chimeras, where the extent of donor cell contribution to the desired tissue or organ can be regulated. However, ethical concerns arise with the use of brain tissue in such chimeras. Furthermore, the ratio of contributed cells to host animal cells in the chimeric system is low in the production of chimeras associated with cell apoptosis. This review discusses the latest innovations in blastocyst complementation and highlights the progress made in creating organs for transplant.</description><identifier>ISSN: 2468-4511</identifier><identifier>EISSN: 2468-4511</identifier><identifier>DOI: 10.1016/j.cobme.2024.100537</identifier><identifier>PMID: 38854436</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Apoptosis ; Blastocyst complementation ; Chimeric embryos ; Ethical concerns ; Gene knockout ; Liver ; Pig ; Transplant</subject><ispartof>Current opinion in biomedical engineering, 2024-09, Vol.31, p.100537, Article 100537</ispartof><rights>2024 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c284t-990ac986660ca9111e054faea81eb1a37dcf35f7ec41f80c96ffc4da9fd64c193</cites><orcidid>0000-0002-5005-3050</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38854436$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahmadzada, Boyukkhanim</creatorcontrib><creatorcontrib>Felgendreff, Philipp</creatorcontrib><creatorcontrib>Minshew, Anna M.</creatorcontrib><creatorcontrib>Amiot, Bruce P.</creatorcontrib><creatorcontrib>Nyberg, Scott L.</creatorcontrib><title>Producing human livers from human stem cells via blastocyst complementation</title><title>Current opinion in biomedical engineering</title><addtitle>Curr Opin Biomed Eng</addtitle><description>The need for organ transplants exceeds donor organ availability. In the quest to solve this shortage, the most remarkable area of advancement is organ production through the use of chimeric embryos, commonly known as blastocyst complementation. This technique involves the combination of different species to generate chimeras, where the extent of donor cell contribution to the desired tissue or organ can be regulated. However, ethical concerns arise with the use of brain tissue in such chimeras. Furthermore, the ratio of contributed cells to host animal cells in the chimeric system is low in the production of chimeras associated with cell apoptosis. This review discusses the latest innovations in blastocyst complementation and highlights the progress made in creating organs for transplant.</description><subject>Apoptosis</subject><subject>Blastocyst complementation</subject><subject>Chimeric embryos</subject><subject>Ethical concerns</subject><subject>Gene knockout</subject><subject>Liver</subject><subject>Pig</subject><subject>Transplant</subject><issn>2468-4511</issn><issn>2468-4511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PwzAMhiMEggn4BUioRy4dyfKx5MABTXyJSXCAc5S5DmRqm5G0k_j3dGwgTpxs2a_92g8hZ4yOGWXqcjmGuGhwPKETMVSo5NM9MpoIpUshGdv_kx-R05yXlFKmJRVaHpIjrrUUgqsReXxOseohtG_Fe9-4tqjDGlMufIrNrpI7bArAus7FOrhiUbvcRfjMXQGxWdXYYNu5LsT2hBx4V2c83cVj8np78zK7L-dPdw-z63kJEy260hjqwGilFAVnGGNIpfAOnWa4YI5PK_Bc-imCYF5TMMp7EJUzvlICmOHH5GK7d5XiR4-5s03ImwNdi7HPllOlOJfGyEHKt1JIMeeE3q5SaFz6tIzaDUi7tN8g7Qak3YIcps53Bv3Qqn5nfrANgqutAIc31wGTzRCwBaxCQuhsFcO_Bl_yBIXh</recordid><startdate>202409</startdate><enddate>202409</enddate><creator>Ahmadzada, Boyukkhanim</creator><creator>Felgendreff, Philipp</creator><creator>Minshew, Anna M.</creator><creator>Amiot, Bruce P.</creator><creator>Nyberg, Scott L.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5005-3050</orcidid></search><sort><creationdate>202409</creationdate><title>Producing human livers from human stem cells via blastocyst complementation</title><author>Ahmadzada, Boyukkhanim ; Felgendreff, Philipp ; Minshew, Anna M. ; Amiot, Bruce P. ; Nyberg, Scott L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c284t-990ac986660ca9111e054faea81eb1a37dcf35f7ec41f80c96ffc4da9fd64c193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Apoptosis</topic><topic>Blastocyst complementation</topic><topic>Chimeric embryos</topic><topic>Ethical concerns</topic><topic>Gene knockout</topic><topic>Liver</topic><topic>Pig</topic><topic>Transplant</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahmadzada, Boyukkhanim</creatorcontrib><creatorcontrib>Felgendreff, Philipp</creatorcontrib><creatorcontrib>Minshew, Anna M.</creatorcontrib><creatorcontrib>Amiot, Bruce P.</creatorcontrib><creatorcontrib>Nyberg, Scott L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in biomedical engineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahmadzada, Boyukkhanim</au><au>Felgendreff, Philipp</au><au>Minshew, Anna M.</au><au>Amiot, Bruce P.</au><au>Nyberg, Scott L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Producing human livers from human stem cells via blastocyst complementation</atitle><jtitle>Current opinion in biomedical engineering</jtitle><addtitle>Curr Opin Biomed Eng</addtitle><date>2024-09</date><risdate>2024</risdate><volume>31</volume><spage>100537</spage><pages>100537-</pages><artnum>100537</artnum><issn>2468-4511</issn><eissn>2468-4511</eissn><abstract>The need for organ transplants exceeds donor organ availability. In the quest to solve this shortage, the most remarkable area of advancement is organ production through the use of chimeric embryos, commonly known as blastocyst complementation. This technique involves the combination of different species to generate chimeras, where the extent of donor cell contribution to the desired tissue or organ can be regulated. However, ethical concerns arise with the use of brain tissue in such chimeras. Furthermore, the ratio of contributed cells to host animal cells in the chimeric system is low in the production of chimeras associated with cell apoptosis. This review discusses the latest innovations in blastocyst complementation and highlights the progress made in creating organs for transplant.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>38854436</pmid><doi>10.1016/j.cobme.2024.100537</doi><orcidid>https://orcid.org/0000-0002-5005-3050</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2468-4511
ispartof Current opinion in biomedical engineering, 2024-09, Vol.31, p.100537, Article 100537
issn 2468-4511
2468-4511
language eng
recordid cdi_proquest_miscellaneous_3066335995
source Alma/SFX Local Collection
subjects Apoptosis
Blastocyst complementation
Chimeric embryos
Ethical concerns
Gene knockout
Liver
Pig
Transplant
title Producing human livers from human stem cells via blastocyst complementation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T16%3A19%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Producing%20human%20livers%20from%20human%20stem%20cells%20via%20blastocyst%20complementation&rft.jtitle=Current%20opinion%20in%20biomedical%20engineering&rft.au=Ahmadzada,%20Boyukkhanim&rft.date=2024-09&rft.volume=31&rft.spage=100537&rft.pages=100537-&rft.artnum=100537&rft.issn=2468-4511&rft.eissn=2468-4511&rft_id=info:doi/10.1016/j.cobme.2024.100537&rft_dat=%3Cproquest_cross%3E3066335995%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3066335995&rft_id=info:pmid/38854436&rft_els_id=S2468451124000175&rfr_iscdi=true